Liquidia CORP Form 4 insider transactions
NASDAQ
LQDA
Liquidia CORPCaligan Partners LP reports a series of transactions involving Liquidia Corp common stock, including an in-kind distribution to limited partners and transactions between Caligan Funds.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) and shares.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of company stock, including transactions related to vested restricted stock units and sales under a Rule 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw of Liquidia Corp reports acquisition and disposal of common stock and restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the acquisition and disposal of common stock and restricted stock units.
NASDAQ
LQDA
Liquidia CORPJason Adair, Chief Business Officer of Liquidia Corp, sold 1,833 shares of common stock on July 26, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 1,873 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp CEO Roger Jeffs sold 8,053 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, sold shares to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) to cover taxes.
NASDAQ
LQDA
Liquidia CORPRussell Schundler, General Counsel of Liquidia Corp, sold 1,985 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes related to the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 3,906 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPDirector Raman Singh acquired 20,359 shares of Liquidia Corp through restricted stock units (RSUs) that vest within one year.
NASDAQ
LQDA
Liquidia CORPForm 4: Liquidia Corp Director Katherine Rielly-Gauvin Reports Acquisition of 20,359 Common Stock Units
Katherine Rielly-Gauvin, a director of Liquidia Corp, reported the acquisition of 20,359 common stock units on June 20, 2024.
NASDAQ
LQDA
Liquidia CORPDirector Paul B. Manning reports acquisition of Liquidia Corp stock through restricted stock units and details beneficial ownership.
NASDAQ
LQDA
Liquidia CORPDirector Arthur Kirsch acquired shares and restricted stock units (RSUs) in Liquidia Corp on June 20, 2024.
NASDAQ
LQDA
Liquidia CORPDavid Edward Johnson, a director and 10% owner of Liquidia Corp, reports the acquisition of restricted stock units convertible to common stock.
NASDAQ
LQDA
Liquidia CORPDirector Joanna Horobin reports acquisition of 20,359 shares of Liquidia Corp common stock through restricted stock units.
NASDAQ
LQDA
Liquidia CORPDirector Damian deGoa acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, as part of a restricted stock unit grant.
NASDAQ
LQDA
Liquidia CORPDirector Stephen M. Bloch acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, through restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting and sale of restricted stock units (RSUs) and common stock transactions.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair of Liquidia Corp reports the vesting and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of company stock, including transactions to cover taxes on vested RSUs.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reports the vesting and subsequent sale of common stock to cover taxes, alongside other holdings.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,649 shares of common stock on April 19, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRussell Schundler, General Counsel of Liquidia Corp, sold 2,060 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,525 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 1,585 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 3,136 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.